皮下过敏原特异性免疫治疗中心建立的初探  

A preliminary study on the establishment of a subcutaneous allergen-specific immunotherapy center

作　　者：卢兵 叶飞[2] 刘光辉 谢青 陈亮 张书辰 Lu Bing;Ye Fei;Liu Guanghui;Xie Qing;Chen Liang;Zhang Shuchen(Department of Allergy,Union Shenzhen Hospital,Huazhong University of Science and Technology,Shenzhen 518000,China;Department of Allergy,Zhongshan City People′s Hospital,Zhongshan 528499,China;Department of Allergy,Zhongnan Hospital,Wuhan University,Wuhan 430071,China)

机构地区：[1]华中科技大学协和深圳医院过敏反应科,深圳518000 [2]中山市人民医院过敏反应科,中山528499 [3]武汉大学中南医院过敏反应科,武汉430071

出　　处：《中华预防医学杂志》2023年第12期1942-1948,共7页Chinese Journal of Preventive Medicine

基　　金：湖北省自然科学基金面上项目(2021CFB308);深圳市南山区卫生健康系统科技重大项目高水平医院卫生健康科技专项(NSZD2023005);深圳市南山区卫生健康系统科技重大项目高水平医院卫生健康科技专项(NSZD2023004)。

摘　　要：过敏性疾病可显著影响患者的生活质量。世界卫生组织已将过敏性疾病列为21世纪需要重点研究和防控的疾病之一。目前,过敏原特异性免疫治疗被认为是可能改变过敏性疾病自然进程的治疗方法,因此被视为防治过敏性疾病的关键措施。然而,过敏原特异性免疫治疗在临床实践中的广泛应用仍面临挑战,其中一个主要的问题是缺乏规范化的皮下过敏原特异性免疫治疗中心。本文阐述了一些关于建立规范化的皮下过敏原特异性免疫治疗中心的意见与建议。Allergic diseases can notably affect a patient′s quality of life.World Health Organization(WHO)has identified these diseases as one of the key areas for research and prevention in the 21st century.Currently,allergen-specific immunotherapy is viewed as a potential treatment approach that could modify the natural progression of allergic diseases,thus being recognized as a crucial tactic in their prevention and treatment.Nonetheless,the broad implementation of allergen-specific immunotherapy in clinical settings continues to confront challenges.One significant issue is the absence of standardized centers for subcutaneous allergen-specific immunotherapy.This article presents several perspectives and recommendations for establishing a standardized subcutaneous allergen-specific immunotherapy center.

关 键 词：过敏性疾病 过敏原特异性免疫治疗 脱敏治疗 规范化 

分 类 号：R593.1[医药卫生—内科学]